Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chordoma.

Paolo G Casali1, Silvia Stacchiotti, Claudia Sangalli

  • 1Adult Sarcoma Medical Oncology Unit, Istituto Nazionale dei Tumori, Milano, Italy. paolo.casali@istitutotumori.mi.it

Current Opinion in Oncology
|June 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiologic response assessment in patients with desmoid-type fibromatosis treated with percutaneous cryoablation.

European radiology experimental·2026
Same author

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Critical reviews in oncology/hematology·2026
Same author

ASO Visual Abstract: Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis using Radiomics: An International Multi-center Cohort Study.

Annals of surgical oncology·2026
Same author

Correction: ASO Visual Abstract: Well‑Differentiated Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes.

Annals of surgical oncology·2026
Same author

Predicting Failure of Active Surveillance in Desmoid-Type Fibromatosis Using Radiomics: An International Multi-center Cohort Study.

Annals of surgical oncology·2026
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Chordoma treatment requires adequate surgical margins, which are challenging to achieve. Advances in radiation therapy and molecular-targeted agents show promise for improving outcomes in this rare bone cancer.

Area of Science:

  • Orthopedic Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Chordoma is a rare bone tumor typically found in the sacrum, skull base, and spine.
  • Surgical resection with adequate margins is crucial for curative treatment but often difficult to achieve due to tumor location.

Purpose of the Study:

  • To review recent developments in chordoma treatment strategies.
  • To highlight advancements in surgical, radiation, and systemic therapies for chordoma.

Main Methods:

  • Review of recent clinical series and literature on chordoma treatment.
  • Evaluation of surgical techniques, radiation modalities (photons and hadrons), and systemic agents.

Main Results:

  • Adequate surgical margins are essential for cure, though challenging to obtain.

Related Experiment Videos

  • Advanced radiation techniques like intensity-modulated radiation therapy and stereotactic procedures are being evaluated.
  • Hadrons offer advantages over photons in specific scenarios.
  • Molecular-targeted agents, such as imatinib, show activity, improving symptoms and progression-free interval.

    • Conclusions:

    • Key unresolved issues in local treatment include optimizing the combination of surgery and radiation therapy and precise high-dose radiation delivery.
    • Systemic treatment research focuses on leveraging molecular-targeted therapies for chordoma.